Empasmart-Sita 25/100 Tablets (Empagliflozin & Sitagliptin)
Empasmart-Sita 25/100 is a diabetes medicine that combines Empagliflozin and Sitagliptin. It helps control blood sugar by removing extra glucose through urine and improving the body’s insulin action. It is used in adults with type 2 diabetes, along with diet and exercise, when single medicines are not enough.
Introduction Of Empasmart-Sita 25/100 Tablets (Empagliflozin + Sitagliptin)
Empagliflozin – an SGLT2 inhibitor that lowers blood sugar by removing excess glucose through urine.
Sitagliptin – a DPP-4 inhibitor that helps the body increase insulin release and reduce sugar production.
This combination helps improve blood sugar control when diet, exercise, and single medicines are not enough. It may also reduce some diabetes-related risks like heart and kidney complications.
Precautions Of Empasmart-Sita 25/100 Tablets
- Kidney function should be monitored; not suitable in severe kidney disease.
- Maintain proper hydration; risk of dehydration and low blood pressure.
- Can cause low blood sugar if taken with insulin or sulfonylureas.
- May cause pancreatitis — report severe abdominal pain immediately.
- Watch for allergic skin reactions or rashes.
- Higher risk of genital or urinary infections.
- Rare risk of diabetic ketoacidosis (symptoms: nausea, vomiting, abdominal pain, breathing trouble).
- Risk of foot ulcers and rare amputations; take foot care seriously.
Uses Of Empasmart-Sita 25/100 Tablets
- Treats Type 2 diabetes in adults.
- Empagliflozin: Increases glucose excretion via urine.
- Sitagliptin: Boosts insulin release and lowers liver glucose production.
- Helps control blood sugar, may aid weight loss.
Side Effects Of Empasmart-Sita 25/100 Tablets
While Empasmart-Sita is generally well-tolerated, some users may experience:
- Urinary tract infections
- Fungal infections
- Upper respiratory tract infections
Serious side effects, though rare, may include:
- Severe joint pain
- Skin reactions like blisters or peeling
- Pancreatitis (inflammation of the pancreas)
- Kidney problems
- Bullous pemphigoid (a rare skin condition)
FAQs Of Empasmart-Sita 25/100 Tablets
Q1: Can I stop taking Empasmart-Sita if my blood sugar becomes normal?
No. Type 2 diabetes is a chronic condition, and stopping medication without medical advice can lead to blood sugar fluctuations. Always consult your doctor before making any changes to your medication regimen.
Q2: Do I need to follow a special diet while taking Empasmart-Sita?
Yes. A balanced diet tailored to your condition is essential. Your doctor or dietitian may provide specific dietary recommendations to optimize the effectiveness of the medication.
Q3: Is it safe to take Empasmart-Sita with other diabetes medications?
Yes, but only under medical supervision. Combining Empasmart-Sita with other diabetes medications, such as insulin or sulfonylureas, may increase the risk of low blood sugar (hypoglycemia). Your doctor will determine the appropriate combination based on your individual needs.
Q4: Can Empasmart-Sita cause dehydration?
Yes. Empagliflozin can increase urination, leading to dehydration. It's important to stay well-hydrated and monitor for signs of dehydration, especially during hot weather or illness.
Q5: Are there any serious side effects?
While uncommon, potential side effects may include urinary tract infections, fungal infections, and upper respiratory tract infections. If you experience symptoms like dizziness, fatigue, or signs of dehydration, contact your healthcare provider promptly.
Interactions Of Empasmart-Sita 25/100 Tablets
- Insulin or sulfonylureas: ↑ risk of low blood sugar.
- Diuretics: ↑ risk of dehydration or low blood pressure.
- Other diabetes meds: May need dose adjustment.
- ACE inhibitors/ARBs: Possible kidney effects.
| Manufacturer | : | Healing Pharma |
| Trade Name | : | Jardiance |
| Generic Search | : | Empagliflozin & Sitagliptin |
| Strength | : | 25 mg + 100 mg |
















